Primobolan depot dosage , lyophilisate for the preparation of a solution for subcutaneous administration, the complex is a protein with a molecular weight 8.5 Kd, differential extraction and isolated by ultrafiltration from the blood leukocytes of healthy donors individually tested for the absence of surface antigen of hepatitis B virus and antibodies to human immunodeficiency virus primobolan depot dosage and hepatitis C.Affinoleukine 1 unit corresponds to the activity of the drug, made from 500 mln. Blood leukocytes. The product does not contain preservatives and antibiotics.Stabilizer – glycine.The amorphous mass of white. Affinoleukine comprises antigen-specific T cell cytokines origin. When failure of cellular immunity of its primobolan depot dosage introduction restores lost and strengthens the oppressed dependent cell immunoreactivity to antigens universally common pathogens such as herpes simplex virus and hepatitis B, Staphylococcus, Streptococcus, Mycobacterium tuberculosis, Corynebacterium, yeast-like fungi, etc.
Appointment. For immunotherapy of cellular immunity deficiency
Indications for use and dosage. The drug is used as an additional component of the complex pharmacotherapy for the treatment of exacerbations of severe and srednetyazhёlyh forms of atopic dermatitis and psoriasis, as well as deep relapsing forms oftalmogerepesa in cases of protracted course or joining a secondary infection. Appointed in adults and children two years of age (data on use in children younger ages are not available).
The contents of the ampoule were dissolved immediately before use in 1 ml of isotonic sodium chloride for primobolan depot dosage 0.9% sodium. The drug should be dissolved in not more than 15 seconds to form a colorless transparent solution containing no insoluble particles.
Affinoleukine administered subcutaneously once per day 1 – 3 times per week, at the first primobolan depot dosage – 0.5 units and in the absence of side reactions increase the administered dose of 0.5 units or 1 to 2 units, depending on the age of the patient.
Single dose for children should not exceed – 1 unit for adolescents and adults -2 units. Heading dose for children, as a rule, – 10 units for adolescents and adults – 20 units.
If after completing the course did not achieve a positive dynamics of the process, it is advisable to continue the course in children up to 15 units, in adults – up to 30 units. With the onset of remission for the prevention of exacerbations should enter 1 units 1-2 times per month. Do not start the prophylactic administration of the drug at the time of remission in patients who have not received the drug for relief of acute. In cases of recurrent course of primobolan depot dosages repeated.
Side effects. In rare cases, the application can sense light Affinoleukine pain and paresthesia in the time of administration, poor flushing of the skin at the primobolan depot dosage site, low-grade fever, in patients with atopic dermatitis and psoriasis, little short-term increase in certain symptoms of dermatitis -giperemii and itching;These reactions may not cause withdrawal of the drug, since, on subsequent primobolan depot dosages are as a rule do not occur.
Interaction with other medicinal products. Not identified. Affinoleukine be administered simultaneously with other drugs, but in a separate syringe.
Contraindications. Hypersensitivity to glycine. Data on the use of Affinoleukine during pregnancy and during lactation is not. Running low dose t3 clen cycle trying to lose bodyfat isn’t a real hot idea imo.